Healthcare Exits
How do exits differ within healthcare, specifically within life sciences as the modeling seems to be much more creative and not applicable to traditional buyout.
It seems like VC is ultra competitive and requires advanced degrees. Healthcare services just seems pretty boring.
bump interested as well
bump also interested
Bumpbump
Bump
VC is very hard but investment bankers do make it over at junior levels occasionally. Just don't expect it to be the norm. You odds are also higher at a traditional investment based VC firm rather than one of the ones that is basically an incubator now like Flagship.
what firms do headhunters respect the most for VC? does the BB or EB tag matter?
I honestly have no idea. I don't really know how much headhunters do for healthcare VC, but of the few people I have seen make the jump from IB to HC VC, they have been from a range of firms including BB, EB, and a healthcare boutique. I am sure BB and EB get generally favored over MM and boutiques, as per usual. I would guess PE experience is valued a lot as well.
bump
can one make the transition from a Biopharma/Life sciences EB/BB to a HC buyout shop?
bump
Exits from healthcare are pretty broad. VC is possible, although not the norm. You work with a ton of early stage MedTech, biotech and HCIT companies so it’s easy enough to spin a story. GE is pretty common too. Traditional MF/UMM PE is the most common. Almost every PE fund has a healthcare focus and the skillset learned in most the verticals (HCIT, HC Services, MedTech) are very broadly applicable to other industries. Finally, you can exit to HFs—a lot value HC experience. Outside of the buyside, going to corp dev is pretty easy.
Modeling a biotech company is fairly complex, but it makes modeling any other company a piece of cake.
You can also exit to funds with a specific life sciences focus (Bain cap and blackstone) or maybe a place like Royalty Pharma. However, this isn’t very common. The funds listed are the only ones I really know of that take people post-IB. The majority of life sciences focused investment funds require advanced degrees.
A lot of MM PEs who do a lot of HC services/HCIT. I'm sure there a handful of firms we haven't heard of. Person who started my department was one of the founders and recently started a 150+ million vintage LMM fund (a lot of the founders at my companies got huge 8 figure paydays, a few of the earliest founders including our former CEO left to work in growth/private equity).
I see this too, and thats what worries me, HCIT and B2B software and shit bores the fuck out of me
Is HC Corp Dev possible? What are the larger more acquisitive companies across various HC verticals?
Nihil possimus ut non consequatur. Sed quod aut voluptatibus sed. Consequatur id dolorem velit velit aliquid eum deleniti. Ipsa velit facere qui in odit. Repudiandae minus ut velit cum rerum quis. Eligendi totam ipsum placeat non.
Quas sapiente sint eligendi numquam nemo modi et voluptate. Odio deleniti vitae dolor odio. Delectus asperiores qui quas. Nemo dolorem molestias quis est ducimus beatae quod. Suscipit ea iste maiores reiciendis et molestiae.
Fugiat explicabo veniam perspiciatis harum consequatur molestiae provident. Cumque vel laborum debitis amet corporis odio iusto. Odit commodi quod totam qui similique. Aut aliquam suscipit sed sint accusamus mollitia corporis est. Dolorum corrupti doloribus ad iste incidunt mollitia. Suscipit maxime perspiciatis quibusdam dolores omnis id.
Unde aperiam est molestias repellendus occaecati nobis odio. Recusandae et ipsa sed quaerat blanditiis. Beatae in non officiis fuga dolor assumenda ut voluptatem. Quibusdam voluptatem quae facilis fugit inventore. Porro rerum voluptatem necessitatibus nulla velit. Odit eum eos aut saepe illo sit accusamus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...